Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mine Diril, Kemal Volkan Özdokur, Yeliz Yıldırım & H. Yeşim Karasulu. (2023) In vitro evaluation and in vivo efficacy studies of a liposomal doxorubicin-loaded glycyrretinic acid formulation for the treatment of hepatocellular carcinoma. Pharmaceutical Development and Technology 0:0, pages 1-13.
Read now
Read now
Anastasia Yu Lokova & Olga V Zaborova. (2019) Modification of fliposomes with a polycation can enhance the control of pH-induced release. International Journal of Nanomedicine 14, pages 1039-1049.
Read now
Read now
Ying Li, Meng Wang, Bu-Wei Huang, Yuan Ping, Jian You & Jian-Qing Gao. (2017) Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery. International Journal of Nanomedicine 12, pages 8557-8572.
Read now
Read now
Articles from other publishers (23)
Amit Dabke, Saikat Ghosh, Pallavi Dabke, Krutika Sawant & Ajay Khopade. (2023) Revisiting the in-vitro and in-vivo considerations for in-silico modelling of complex injectable drug products. Journal of Controlled Release 360, pages 185-211.
Crossref
Crossref
Catherine Saunders, James E. J. Foote, Jonathan P. Wojciechowski, Ana Cammack, Simon V. Pedersen, James J. Doutch, Hanna M. G. Barriga, Margaret N. Holme, Jelle Penders, Mohamed Chami, Adrian Najer & Molly M. Stevens. (2023) Revealing Population Heterogeneity in Vesicle-Based Nanomedicines Using Automated, Single Particle Raman Analysis. ACS Nano 17:12, pages 11713-11728.
Crossref
Crossref
Anna Pogorzelska, Maciej Mazur, Marta Świtalska, Joanna Wietrzyk, Dawid Sigorski, Krzysztof Fronczyk & Katarzyna Wiktorska. (2023) Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model. Biomedicine & Pharmacotherapy 161, pages 114490.
Crossref
Crossref
Yingqian Zhong, Yuyu Zhou, Ruoyi Ding, Luxiang Zou, Hongyu Zhang, Xiaohui Wei & Dongmei He. (2023) Intra-articular treatment of temporomandibular joint osteoarthritis by injecting actively-loaded meloxicam liposomes with dual-functions of anti-inflammation and lubrication. Materials Today Bio 19, pages 100573.
Crossref
Crossref
Marco Hoffmann, Sven Gerlach, Christina Hoffmann, Nathalie Richter, Nils Hersch, Agnes Csiszár, Rudolf Merkel & Bernd Hoffmann. (2022) PEGylation and folic-acid functionalization of cationic lipoplexes—Improved nucleic acid transfer into cancer cells. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Riddhi Trivedi & Pravin Shende. (2022) Nanotech-based Food: An Initiative for Alternative Pharmaceuticals. Current Pharmaceutical Biotechnology 23:14, pages 1739-1749.
Crossref
Crossref
Shruti S. Sawant, Suyash M. Patil, Snehal K. Shukla, Nishant S. Kulkarni, Vivek Gupta & Nitesh K. Kunda. (2021) Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation. Drug Delivery and Translational Research 12:10, pages 2474-2487.
Crossref
Crossref
Nour Al Sawaftah, Vinod Paul, Nahid Awad & Ghaleb A. Husseini. (2021) Modeling of Anti-Cancer Drug Release Kinetics From Liposomes and Micelles: A Review. IEEE Transactions on NanoBioscience 20:4, pages 565-576.
Crossref
Crossref
Masanobu Shiga, Jun Miyazaki, Kozaburo Tanuma, Yoshiyuki Nagumo, Takayuki Yoshino, Shuya Kandori, Hiromitsu Negoro, Takahiro Kojima, Ryota Tanaka, Naoko Okiyama, Yasuhiro Fujisawa, Miyuki Watanabe, Sho Yamasaki, Hideyasu Kiyohara, Makoto Watanabe, Taka-aki Sato, Hideaki Tahara, Hiroyuki Nishiyama & Ikuya Yano. (2021) The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells. Cancer Immunology, Immunotherapy 70:9, pages 2529-2543.
Crossref
Crossref
Leonidas Gkionis, Harmesh Aojula, Lynda K. Harris & Annalisa Tirella. (2021) Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics. International Journal of Pharmaceutics 604, pages 120711.
Crossref
Crossref
Nicola d'Avanzo, Giulia Torrieri, Patrícia Figueiredo, Christian Celia, Donatella Paolino, Alexandra Correia, Karina Moslova, Tambet Teesalu, Massimo Fresta & Hélder A. Santos. (2021) LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy. International Journal of Pharmaceutics 597, pages 120346.
Crossref
Crossref
R. Díaz de León–Ortega, D.M. D'Arcy, D.A. Lamprou, W.F. Xue & N. Fotaki. (2021) In vitro in vivo relations for the parenteral liposomal formulation of Amphotericin B: A biorelevant and clinically relevant approach. European Journal of Pharmaceutics and Biopharmaceutics 159, pages 188-197.
Crossref
Crossref
Jarosław Ciekot, Mateusz Psurski, Katarzyna Jurec & Janusz Boratyński. (2020) Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy. Investigational New Drugs 39:1, pages 15-23.
Crossref
Crossref
Karim Dadashi Noshahr, Fahimeh Shamsi, Peter Valtchev, Parviz Kokhaei, Maral Hemati, Mohammad Reza Akbari Eidgahi & Ali Khaleghian. (2020) Optimization of post-insertion method to conjugate Doxil with anti-CD133 monoclonal antibodies: Investigating the specific binding and cytotoxicity to colorectal cancer cells in vitro. Saudi Pharmaceutical Journal 28:11, pages 1392-1401.
Crossref
Crossref
Roberto Molinaro, Jonathan O. Martinez, Assaf Zinger, Alessandro De Vita, Gianluca Storci, Noemi Arrighetti, Enrica De Rosa, Kelly A. Hartman, Nupur Basu, Nima Taghipour, Claudia Corbo & Ennio Tasciotti. (2020) Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma. Biomaterials Science 8:1, pages 333-341.
Crossref
Crossref
Lingwei Meng, Xiaoyang Chu, Haoyue Xing, Xuan Liu, Xin Xin, Liqing Chen, Mingji Jin, Youyan Guan, Wei Huang & Zhonggao Gao. (2019) Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol. International Journal of Pharmaceutics 567, pages 118485.
Crossref
Crossref
Ji-Hun Jang, Seung-Hyun Jeong & Yong-Bok Lee. (2019) Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery. International Journal of Molecular Sciences 20:13, pages 3312.
Crossref
Crossref
Hassan Tamam, Jinho Park, Hytham H. Gadalla, Andrea R. Masters, Jelan A. Abdel-Aleem, Sayed I. Abdelrahman, Aly A. Abdelrahman, L. Tiffany Lyle & Yoon Yeo. (2019) Development of Liposomal Gemcitabine with High Drug Loading Capacity. Molecular Pharmaceutics 16:7, pages 2858-2871.
Crossref
Crossref
Roberto Gonzalez-Rodriguez, Elizabeth Campbell & Anton Naumov. (2019) Multifunctional graphene oxide/iron oxide nanoparticles for magnetic targeted drug delivery dual magnetic resonance/fluorescence imaging and cancer sensing. PLOS ONE 14:6, pages e0217072.
Crossref
Crossref
Fatemeh Keivani Nahr, Babak Ghanbarzadeh, Hamed Hamishehkar, Hossein Samadi Kafil, Mohammadyar Hoseini & Behnam Esmaeilnejad Moghadam. (2019) Investigation of physicochemical properties of essential oil loaded nanoliposome for enrichment purposes. LWT 105, pages 282-289.
Crossref
Crossref
Eiichi Yamamoto. (2019) <i>In Vitro</i> Release Method for Liposome Drug Productsリポソーム製剤の研究開発における薬物放出評価法. YAKUGAKU ZASSHI 139:2, pages 249-254.
Crossref
Crossref
Eiichi Yamamoto, Kenji Hyodo, Takuya Suzuki, Hiroshi Ishihara, Hiroshi Kikuchi & Masaru Kato. (2018) Simulation of Stimuli-Responsive and Stoichiometrically Controlled Release Rate of Doxorubicin from Liposomes in Tumor Interstitial Fluid. Pharmaceutical Research 35:5.
Crossref
Crossref
Baomin Zhu, Huanying Zhang & Lianling Yu. (2017) Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation. Biomedicine & Pharmacotherapy 86, pages 547-554.
Crossref
Crossref